Experience

Digma Medical

• Israel
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director of Preclinical & Clinical Research and QA Director

  • Mar 2022 - Present

  Digma aims to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that enable them to live longer, healthier and happier lives.We are developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels. The treatment targets the intestinal tract which is central to nutrient sensing and metabolic signaling.Our product consists of a console and a single-use catheter that is compatible with the working channel of standard gastrointestinal endoscopes. The EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. Our goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy.The EGM procedure is currently being evaluated in clinical studies. Show less

• Director of Research & QA Manager

  • Nov 2012 - Present



Arkin Holdings

• Analyst

  • Jul 2010 - Nov 2012



Accelmed

• United States
• Investment Management
• 1 - 100 Employee

• Analyst

  • 2008 - 2010



Webb & Co.

• Israel
• Law Practice
• 1 - 100 Employee

• Patent attorney intership

  • 2007 - 2008



BTG A Ferring Company

• Israel
• Biotechnology Research
• 200 - 300 Employee

• Research Assistant, Biological Applications Department

  • 1999 - 2000